[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Centre Hospitalier Sud Francilien\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":333},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,12,0,[8,43,76,103,136,160,186,214,243,269,290,311],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100642668","barriers-and-facilitators-to-psychosocial-management-in-cardiac-rehabilitation-at-the-south-francilien-hospital-center-chsf-100642668",false,"NCT07651501","Barriers and Facilitators to Psychosocial Management in Cardiac Rehabilitation at the South Francilien Hospital Center (CHSF)","PSYRCV","Inclusion Criteria:\n\n* Male and female, legally adult patients, participating in a cardiac rehabilitation program in day hospital at the CHSF\n* Active in the workforce\n* Planning to return to work\n* Patients informed of the study and who did not object to it\n\nExclusion Criteria:\n\n* Patient under legal guardianship\n* Presence of cognitive impairments\n* Patients who do not speak nor understand French.","ALL","18 Years",{"count":19,"type":20},20,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to describe the barriers to psychosocial management in cardiac rehabilitation patients at the south francilien hospital center (CHSF) and understand how to improve it, in order to facilitate their return to work.\n\nThe main questions it aims to answer are :\n\n* What are the perceived barriers to psychosocial management among the male and female cardiac rehabilitation patients at the CHSF ?\n* What are the perceived barriers to psychosocial management among the medical, paramedical and administrative staff members of the cardiac rehabilitation service at the CHSF ?",[24],"Cardiac Rehabilitation",[26,27,28,29],"cardiac rehabilitation","Psychosocial intervention","Occupational health","Return to work","NOT_YET_RECRUITING","2026-06-11",{"date":33,"type":34},"2026-06-16","ACTUAL",{"date":36,"type":20},"2026-09-01",{"date":38,"type":20},"2026-12-31",{"name":40,"class":41},"Centre Hospitalier Sud Francilien","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":61,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},"100626027","hybrid-closed-loop-insulin-delivery-after-pancreatectomy-100626027","NCT07430293","Hybrid Closed-Loop Insulin Delivery After Pancreatectomy","Metabolic Effects of Hybrid Closed-loop Insulin Delivery in People With Diabetes After Pancreatectomy: a Randomized Cross-over Controlled Trial","HCL PP","Inclusion Criteria:\n\n1. Age from 18 years\n2. History of total or partial pancreatectomy with random C-peptide \\\u003C 0.3 ng\u002FmL and concomitant blood glucose between 120 and 225 mg\u002FdL (no minimum delay required since surgery)\n3. Total daily insulin dose between 6 units and 250 units\n4. Be affiliated to a French social security scheme\n5. Individual able and willing to provide written informed consent\n\nExclusion Criteria:\n\n1. Presence of diabetic retinopathy at or beyond severe non-proliferative diabetic retinopathy, not stabilized by ophthalmologic treatment\n2. Usual diabetes treatment with an insulin pump coupled with continuous glucose monitoring with a \"suspend before hypoglycemia\" system\n3. Pregnant woman or planned pregnancy within the next 6 months\n4. Planned chemotherapy within the next 6 months\n5. Enteral or parenteral nutrition\n6. Estimated life expectancy less than 12 months\n7. Cognitive or psychiatric disorders compromising the individual's autonomy to manage automated insulin delivery\n8. Person taking part in another research study or with an exclusion period still in progress\n9. Individual under legal guardianship or curatorship\n10. Any contraindication mentioned in the instructions for use of the MiniMed 780 - Simplera\n11. Imprisoned or otherwise deprived of liberty",{"count":52,"type":20},24,"INTERVENTIONAL",[55],"NA","Individuals with diabetes secondary to pancreatectomy experience impaired quality of life, partly due to the challenges of managing highly variable blood glucose levels. Hybrid closed-loop (HCL) automated insulin delivery (AID) systems, widely evaluated in type 1 diabetes, may improve both metabolic outcomes and quality of life in this population.\n\nA review of the literature identified a few observational studies reporting promising results with HCL systems in the context of post-pancreatectomy diabetes. Only one randomized trial has evaluated AID in this population, showing excellent outcomes, but using a complex bihormonal system that is not yet commercially available worldwide. Consequently, there remains a lack of confirmatory evidence regarding the efficacy of commercially available monohormonal HCL systems in individuals with diabetes secondary to pancreatectomy, evidence that is crucial to support broader access to this technology.\n\nThe intervention will consist in a 3-month AID treatment combining MiniMed 780 and Simplera.\n\nThe control period will consist in 3 months using the Simplera for continuous glucose monitoring, alongside participant usual diabetes treatment.\n\nThe primary outcome is the percentage of time that interstitial glucose levels remain within the target range (70-180 mg\u002FdL), as measured by continuous glucose monitoring (CGM, Simplera), over a 3-month period using the MiniMed 780 hybrid closed-loop system, compared to a 3-month period under the participant's usual diabetes treatment.",[58,59,60],"Pancreatectomy","Total Pancreatectomy","Partial Pancreatectomy",[62,63,64,65],"diabetes","pancreatectomy","hybrid cloosed-loop","automatised insulin delivery","RECRUITING","2026-05-26",{"date":69,"type":34},"2026-05-28",{"date":71,"type":34},"2026-05-19",{"date":73,"type":20},"2027-11-19",{"name":40,"class":41},2,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":16,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":87,"conditions":88,"keywords":90,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":102,"locationsCount":42},"100631056","reactions-to-oro-facial-solicitations--a-predictor-of-eating-difficulties-for-premature-babies-of-36-weeks-gestation-adjusted-age-100631056","NCT07495709","Reactions to Oro-facial Solicitations : a Predictor of Eating Difficulties for Premature Babies of 36 Weeks Gestation Adjusted Age","RESOF-36","Inclusion Criteria:\n\n* Premature babies born between 26 and 27 + 6 weeks of gestation\n* Admitted to the CHSF between 1 May 2025 and 31 March 2026\n* Criteria grid completed upon admission\n* Parents or guardians informed of the study and not opposed to it.\n\nExclusion Criteria:\n\n* ENT malformation\n* Neurological pathology\n* Dysplasia or oxygen therapy greater than or equal to 0.3L\u002Fmin (these children are seen systematically)\n* Extreme prematurity (gestational age less than 26 weeks)\n* Genetic syndrome\n* Anoxic-ischaemic encephalopathy\n* Digestive malformation","26 Weeks","28 Weeks",{"count":86,"type":20},80,"The goal of this observational study is to assess the link between reactions to orofacial stimuli observed at 29 weeks of amenorrhoea, and feeding difficulties at 36 weeks of amenorrhoea, in babies born prematurely between 26 and 27 + 6 weeks of gestation, admitted to the CHSF between 1 May 2025 and 31 March 2026. The main questions it aims to answer are : Can reactions to orofacial stimulation in babies born very prematurely be used as a tool for early detection of feeding difficulties before discharge from hospital? Is it possible to establish a predictive score for potential feeding difficulties as early as 29 weeks of gestation corrected, based on reactions to orofacial stimuli ? Participants will have their reactions to orofacial stimulations recorded in the 'Suivi oralité' grid completed by the nurses in the neonatal medicine and intensive care unit, which will then collect.",[89],"Premature",[91,92,93,94,95],"premature","Early intervention","orofacial stimulation","feeding difficulties","orality","2026-03-24",{"date":98,"type":34},"2026-03-27",{"date":100,"type":20},"2026-04-01",{"date":38,"type":20},{"name":40,"class":41},{"id":104,"slug":105,"hasResults":11,"nctId":106,"briefTitle":107,"officialTitle":107,"acronym":108,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":16,"minAge":110,"maxAge":4,"enrollmentInfo":111,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":113,"conditions":114,"keywords":118,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":129,"lastUpdatePostDateStruct":130,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":135,"locationsCount":42},"100624788","study-of-pre-hospital-management-of-polytrauma-patients-by-medical-teams-from-a-department-in-the-parisian-region-100624788","NCT07414186","Study of Pre Hospital Management of Polytrauma Patients by Medical Teams From a Department in the Parisian Region","DELTA-91","Inclusion Criteria:\n\n* Age ≥ 15 years (upper age limit for the pediatric population)\n* Severe trauma, defined as any road traffic accident, defenestration, fall from a height greater than 3 meters, stab wound, or ballistic injury requiring medically supervised transport to one of the Level 1 trauma centers in the Île-de-France region\n* Prehospital management provided by one of the SMUR teams in the Essonne department (91)\n\nExclusion Criteria:\n\n* Patients declared dead at initial medical contact, without resuscitation initiated, or with resuscitation attempted and subsequently discontinued (non-return of spontaneous circulation)\n* Secondary inter-hospital transfer from another hospital to a Level 1 trauma center\n* Transport to a hospital for local computed tomography imaging only (without direct admission to a Level 1 trauma center)\n* Cases regulated (dispatched) by emergency coordination centers other than the Essonne (91) medical dispatch center","15 Years",{"count":112,"type":20},400,"To study the impact of prehospital management duration by SMUR teams in the Essonne department (91) on early patient mortality (within 24 hours) and to analyze the procedures performed on scene.\n\nThe study hypothesis is that all-cause in-hospital mortality may be associated with the duration of prehospital care, with either a beneficial impact related to the performance of life-saving interventions or a negative impact due to prolonged time to access definitive treatment.\n\nIdentifying potential factors associated with prolonged prehospital management times could help define possible areas for improvement and future interventions.",[115,116,117],"Traumatic Injuries","Prehospital Emergency Care","Early Mortality",[119,120,121,122,123,124,125,126,127,128],"prehospital emergency care","emergency medical services","wounds and injuries","trauma severity","time-to-treatment","on-scene time","early mortality","in-hospital mortality","advanced life support","emergency medical procedures","2026-02-10",{"date":131,"type":34},"2026-02-17",{"date":133,"type":20},"2026-03-01",{"date":38,"type":20},{"name":40,"class":41},{"id":137,"slug":138,"hasResults":11,"nctId":139,"briefTitle":140,"officialTitle":141,"acronym":142,"eligibilityCriteria":143,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":144,"targetDuration":4,"studyType":53,"phases":146,"briefSummary":147,"conditions":148,"keywords":150,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":152,"lastUpdatePostDateStruct":153,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":159,"locationsCount":42},"100572522","buddy-tape-vs-splint-for-metacarpal-shaft-fracture-recovery-100572522","NCT06734364","Buddy Tape vs. Splint for Metacarpal Shaft Fracture Recovery","Functional Treatment of Non-thumb Metacarpal Shaft Fractures. Randomized Study Evaluating Buddy Taping Versus Splint on Functional Recovery of the Hand","SYNATIP","Inclusion Criteria:\n\n1. Adult patient\n2. Fingers 2 to 5 metacarpal shaft fracture, little or no displacement\n3. Tilt less than or equal to thirty degrees\n4. No rotation disorder\n5. Patient who has given consent to participate in the study and has signed an informed consent\n\nExclusion Criteria:\n\n1. Surgical treatment indicated\n2. Patient pregnant or likely to be pregnant\n3. Patient who does not speak or understand French\n4. Subject under guardianship or curatorship\n5. Subject not beneficiary of a social security system.",{"count":145,"type":20},96,[55],"The goal of this clinical trial is to see if buddy tape can treat shaft fracture of hand long fingers as well as splint.\n\nThe main question it aims to answer is: Two months after the fracture, are the hand activities as good with buddy taping as with splint? Researchers will compare buddy tape group to splint group to see if the strength of the arm is not lower with buddy tape.\n\nParticipants will attend 4 visits after receiving either buddy tape or splint, to control their hand strength and the correct healing of their franture.",[149],"Non-thumb Metacarpal Shaft Fracture",[151],"Metacarpal shaft fracture","2025-12-17",{"date":154,"type":34},"2025-12-23",{"date":156,"type":34},"2025-11-05",{"date":158,"type":20},"2027-02-05",{"name":40,"class":41},{"id":161,"slug":162,"hasResults":11,"nctId":163,"briefTitle":164,"officialTitle":164,"acronym":165,"eligibilityCriteria":166,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":167,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":169,"conditions":170,"keywords":172,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":178,"lastUpdatePostDateStruct":179,"startDateStruct":181,"completionDateStruct":183,"leadSponsor":185,"locationsCount":42},"100606920","vap-incidence-and-adequation-to-srlf-2017-diagnostic-among-an-intensive-care-medicine-service-for-the-period-2022--2024-100606920","NCT07181824","VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024","PAVM-RéaCHSF","Inclusion Criteria:\n\n* Adults ≥ 18 years\n* Hospitalization in Intensive care unit for the period between 01\u002F01\u002F2022 and 31\u002F12\u002F2024\n* Intubation and mechanical ventilation for \\> 48h\n* Positive respiratory sample\n\nExclusion Criteria:\n\n* Decision of therapeutic limitation\n* Organ donors\n* Patient refuse to participate",{"count":168,"type":20},100,"The goal of this observational study is to to analyze respiratory samples performed in mechanically ventilated ICU patients and to assess whether the SRLF criteria for defining VAP were respected among patients admited to the Intensive care medicine at a regional hospital en France",[171],"Pneumonia Ventilator Associated",[173,174,175,176,177],"Ventilatory associated pneumonia","VAP","Intensive Care medicine","Mechanical ventilation","Pneumonia","2025-12-08",{"date":180,"type":34},"2025-12-09",{"date":182,"type":34},"2025-08-25",{"date":184,"type":20},"2026-06-30",{"name":40,"class":41},{"id":187,"slug":188,"hasResults":11,"nctId":189,"briefTitle":190,"officialTitle":191,"acronym":192,"eligibilityCriteria":193,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":194,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":196,"conditions":197,"keywords":199,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":178,"lastUpdatePostDateStruct":208,"startDateStruct":210,"completionDateStruct":212,"leadSponsor":213,"locationsCount":4},"100604018","impact-of-non-medicalized-ecg-practices-initiated-by-samu-in-dispatch-strategies-100604018","NCT07144059","Impact of Non-medicalized ECG Practices Initiated by SAMU in Dispatch Strategies","Participants Are Not Assigned to Interventions Based on a Protocol","ECG-PHNM","Inclusion Criteria:\n\n* Adult patient\n* Patient regulated by the SAMU 91 between 09\u002F2023 and 12\u002F2024\n* Patient referred for coronary angiography for ST+ ACS\n* Patient registered in the E-Must register (Registry for the Evaluation in Emergency Medicine of Therapeutic Strategies for Myocardial Infarction of less than 24 hours treated by the SAMU\u002FSMUR of Île-de-France)\n\nExclusion Criteria:\n\n* Secondary transport",{"count":195,"type":20},350,"The performance of an ECG by non-medicalized prehospital teams (firefighters, first responders, paramedic ambulances) is developing across the territory to cope with the increasing demand (SAMU calls) for a service that cannot meet it (limited Mobile Emergency and Resuscitation Unit - SMUR - teams).\n\nEarly diagnosis of acute coronary syndrome is key to appropriate management. A delay in care can quickly lead to complications ranging from rhythm disorders to cardiac arrest. Furthermore, as with reperfusion in strokes, the earlier reperfusion treatment is initiated, the greater the beneficial effect in ST-segment elevation myocardial infarction (STEMI).\n\nMoreover, the main elements for diagnosing STEMI in the prehospital setting remain the ECG, along with the anamnesis (medical history) and clinical examination (typical pain).\n\nThis is an observational, retrospective and single-center study (SAMU 91) carried out between September 1, 2023 and December 31, 2024. The inclusion criteria for our study were adult patients who had been regulated by SAMU 91 during a primary intervention and who had ST+ ACS registered in the eMUST registry. The main objective was to study the difference in the admission times of patients admitted to the emergency intensive care unit of cardiology or coronary angiography and presenting with ST+ ACS on the ECG performed by a primary SMUR team versus a non-medical team referred by the SAMU. The secondary objectives were to study the descriptive variables between the two groups (SMUR and non-medicalized vector), the typicity of pain, the mortality rate and the morbidity rate between the two groups.",[198],"Acute Coronary Syndromes",[200,201,202,203,204,205,206,207],"Acute coronary syndrome","infarct","STEMI","Electrocardiogram (ECG)","Coronary angiography","SAMU","SMUR","Non-medical vectors",{"date":209,"type":34},"2025-12-16",{"date":211,"type":20},"2026-02-01",{"date":38,"type":20},{"name":40,"class":41},{"id":215,"slug":216,"hasResults":11,"nctId":217,"briefTitle":218,"officialTitle":218,"acronym":219,"eligibilityCriteria":220,"healthyVolunteers":11,"sex":16,"minAge":221,"maxAge":4,"enrollmentInfo":222,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":224,"conditions":225,"keywords":227,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":178,"lastUpdatePostDateStruct":237,"startDateStruct":238,"completionDateStruct":240,"leadSponsor":242,"locationsCount":42},"100518967","metagenomic-analysis-of-bacterial-microbiota-in-breast-milk-100518967","NCT06037421","Metagenomic Analysis of Bacterial Microbiota in Breast Milk","MIC-LAMA2","Inclusion Criteria:\n\n* Women of legal age who have given birth at the CHSF (or in another establishment) and whose newborn(s) are being cared for in the CHSF's Neonatal Medicine and Intensive Care Unit,\n* Women wishing to give their milk to their child,\n* Parents who have given their consent for the mother-child couple to take part in the study.\n\nExclusion Criteria:\n\n* Mother having received antibiotic therapy in the 3 months prior to delivery, except for those who received injectable antibiotic prophylaxis during delivery.","1 Hour",{"count":223,"type":20},120,"The aim of this study is to determine the extent to which bacteria in the breast milk microbiota represent an infectious risk for premature infants, by investigating whether they possess virulence genes, and if so, whether these are expressed or repressed.",[226],"Bacteria in Breast Milk",[228,229,230,231,232,233,234,235,236],"Bacterial","newborn breast milk","neonates","infectious risk","virulence genes","agar culture methods","shotgun metagenomics","targeted metagenomics","microbiota",{"date":209,"type":34},{"date":239,"type":34},"2025-09-08",{"date":241,"type":20},"2028-12-31",{"name":40,"class":41},{"id":244,"slug":245,"hasResults":11,"nctId":246,"briefTitle":247,"officialTitle":247,"acronym":248,"eligibilityCriteria":249,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":250,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":252,"conditions":253,"keywords":256,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":261,"lastUpdatePostDateStruct":262,"startDateStruct":264,"completionDateStruct":266,"leadSponsor":268,"locationsCount":42},"100551968","study-of-ventilator-associated-event-during-intensive-care-after-resuscitated-cardiac-arrest-100551968","NCT06466980","Study of Ventilator Associated Event During Intensive Care After Resuscitated Cardiac Arrest.","VAE-ACR","Inclusion Criteria:\n\n* Adult male or female\n* Non-pregnant female\n* Successfully resuscitated from cardiac arrest during primary care\n* Invasive mechanical ventilation initiated during resuscitation and continued for at least 4 days\n* No decision to limit life-sustaining therapies within 24 hours following admission to intensive care\n* No requirement of arteriovenous circulatory support during intensive care management\n\nExclusion Criteria\n\n\\- patients who opposed to the use of their data",{"count":251,"type":20},150,"The aim is to describe the incidence, characteristics, risk factors and outcome of complications acquired under mechanical ventilation (called ventilator-associated events) according to the new CDC criteria, in a population of patients admitted in intensive care unit after cardiac arrest.",[254,255],"Cardiac Arrest With Successful Resuscitation","Mechanical Ventilation",[257,258,259,260],"Ventilator associated event","cardiac arrest","ventilator-acquired pneumonia","ventilator associated pneumonia","2025-03-12",{"date":263,"type":34},"2025-03-14",{"date":265,"type":34},"2024-06-27",{"date":267,"type":20},"2025-12-31",{"name":40,"class":41},{"id":270,"slug":271,"hasResults":11,"nctId":272,"briefTitle":273,"officialTitle":273,"acronym":274,"eligibilityCriteria":275,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":276,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":278,"conditions":279,"keywords":281,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":261,"lastUpdatePostDateStruct":285,"startDateStruct":286,"completionDateStruct":288,"leadSponsor":289,"locationsCount":42},"100530911","impact-of-smart-connected-insulin-pens-on-quality-of-life-in-dependent-patients-with-diabetes-using-continuous-glucose-measurement-100530911","NCT06192940","Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement","BESTYLCO","Inclusion Criteria:\n\n* Older than 18 years patient with type 1 or 2 diabetes\n* Treated with multiple insulin injections\n* Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before\n* Dependent on a health professional for treatment management.\n* Subject informed of the study and not objecting to data collection.\n\nExclusion Criteria:\n\n\\- Patient refusing study.",{"count":277,"type":20},30,"Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and\u002For institutionalized patients?",[280],"Diabetes",[282,283,284],"insulin practice","Dependent patient","Smart connected insulin pen",{"date":263,"type":34},{"date":287,"type":34},"2024-03-28",{"date":267,"type":20},{"name":40,"class":41},{"id":291,"slug":292,"hasResults":11,"nctId":293,"briefTitle":294,"officialTitle":295,"acronym":296,"eligibilityCriteria":297,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":298,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":299,"conditions":300,"keywords":302,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":261,"lastUpdatePostDateStruct":306,"startDateStruct":307,"completionDateStruct":309,"leadSponsor":310,"locationsCount":42},"100450049","evaluation-of-the-benefit-of-exercise-testing-for-the-diagnosis-of-obstruction-in-the-coronary-arteries-of-the-heart-100450049","NCT05140434","Evaluation of the Benefit of Exercise Testing for the Diagnosis of Obstruction in the Coronary Arteries of the Heart","Evaluation of the Predictive Power of Double-product Increase Measured During an Exercise Test for the Prediction of Coronary Stenosis As Diagnosed by Cardiac CT Scan or Coronary Angiography.","DP-Cor-1","Inclusion Criteria:\n\n* Starting betweew 1\u002F1\u002F2019 and 3\u002F1\u002F2022\n* 18 year-old patients or older\n* Patients with both exercise testing and either Cardiac CT or coronary angiography within 3 months\n* Patients informed and not opposing to their participation to the study\n\nExclusion Criteria:\n\n* Patients unable to fully understand the information related to the study",{"count":223,"type":20},"The purpose of this study is to determine whether exercise testing can detect an obstruction in a coronary artery, and, thereby, can avoid performing a coronary imaging in some cases.\n\nPatients with a suspicion of coronary artery disease perform an exercise test on an exercise bike with increasing load. EKG, blood pressure, and other parameters are monitored. Patients benefit also of either a cardiac CT scan or a coronary angiography to establish whether they really have coronary obstruction.",[301],"Coronary Artery Disease",[303,304,305],"Exercise testing","coronary stenosis","double product",{"date":263,"type":34},{"date":308,"type":34},"2022-05-04",{"date":267,"type":20},{"name":40,"class":41},{"id":312,"slug":313,"hasResults":11,"nctId":314,"briefTitle":315,"officialTitle":316,"acronym":317,"eligibilityCriteria":318,"healthyVolunteers":319,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":320,"phases":4,"briefSummary":321,"conditions":322,"keywords":324,"overallStatus":327,"whyStopped":4,"lastUpdateSubmitDate":328,"lastUpdatePostDateStruct":329,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":331,"locationsCount":332},"100249747","study-on-pressure-values-measured-on-three-alternative-sites-of-the-lower-limbs-compared-to-the-arm-100249747","NCT02529735","Study on Pressure Values Measured on Three Alternative Sites of the Lower Limbs Compared to the Arm","Etude Prospective Observationnelle Multicentrique Sur Volontaires Sains Des VALeurs de Pression Artérielle mesurées Sur Trois Sites alteRnAtIfS Des Membres inférieurs cOmparées au Site de référence","VALPARAISO","Inclusion Criteria:\n\n* Adults aged 18 and over, without upper age limit\n* Recipient of a social protection scheme or entitled\n* Signature of informed consent\n\nExclusion Criteria:\n\n* During Pregnancy\n* known disease\n* current treatment\n* cardiovascular history\n* Skin lesions in relation to the measurement sites\n* Special anatomically incompatible with blood pressure measurements\n* No one opposing the use of their data\n* Participation in a trial Ongoing clinical\n* Person who participated in the study",true,"EXPANDED_ACCESS","Non-invasive measurement of blood pressure is an instrument governed nursing routine care. The use of an automated oscillometric cuff is a common technique and validated if this is done on the arm with a suitable cuff, positioned opposite the brachial artery and up to the right atrium (the brachial site) . If cons-indication to use the brachial site, measurements are frequently performed at the ankle, calf or thigh. Among the blood pressure values measured on the 3 sites of the lower limb (thigh, calf or ankle), it may be a specific property of which the observed values are closest to the reference values (brachial).\n\nThe objective of this study is to measure the non-invasive blood pressure values at three sites of the lower limb, to compare the reference value to determine which alternative site should be preferred when the reference measurement is not feasible .\n\nWe want to determine the alternative site to obtain values as close as the measured values of the reference site. The three study sites are the thigh, calf and ankle. The reference site recommended for monitoring non-invasive blood pressureis the arm.\n\nIt is also assessing the impact of certain parameters on the primary endpoint:\n\n* Physiological parameters: gender, weight, height, age, systolic blood pressure reference, listed measures.\n* A parameter related to measurement: discomfort felt when the blood pressure outlet.\n* Exposure setting: smoking.",[323],"Blood Pressure",[325,326],"blood pressure","alternative measure","AVAILABLE","2019-10-17",{"date":330,"type":34},"2019-10-21",{"name":40,"class":41},8,""]